TGF-β1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells

Kidney International

Volumn 55, Issue 5, 1999, Pages 1704-1712

  Inoki, Ken ^a   Haneda, Masakazu ^a   Maeda, Shiro ^a   Koya, Daisuke ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Brain type glucose transporter; Diabetic nephropathy; Extracellular matrix; Glomerular mesangial cells; Glucose transport; Transforming growth factor

Indexed keywords

CYCLOHEXIMIDE; DEOXYGLUCOSE; GLUCOSE TRANSPORTER; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DOSE TIME EFFECT RELATION; EXTRACELLULAR MATRIX; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; IMMUNOBLOTTING; MALE; MESANGIUM CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0032893293     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00438.x     Document Type: Article

References (46)

1. 1. MAUER SM, STEFFES MW, ELLIS EN, SUTHERLAND DER, BROWN DM, GOETZ FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
2. 2. STEFFES MW, ØSTERBY R, CHAVERS B, MAUER SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081, 1989
3. 3. NERLICH A, SCHLEICHER E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889-899, 1991
4. 4. STEFFES MW, BILOUS RW, SUTHERLAND DER, MAUER SM: Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41:679-684, 1992
5. 5. KREISBERG JI, AYO SH: The glomerular mesangium in diabetes mellitus. Kidney Int 43:109-113, 1993
6. 6. AYO SH, RADNIK RA, GARONI JA, GLASS WF II, KREISBERG JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136:1339-1348, 1990
7. 7. ZIYADEH FN, SHARMA K, ERICKSEN M, WOLF G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
8. 8. HANEDA M, KIKKAWA R, HORIDE N, TOGAWA M, KOYA D, KAJIWARA N, OOSHIMA A, SHIGETA Y: Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34:198-200, 1991
9. 9. KREISBERG JI, KLEISBERG SH: High glucose activates protein kinase C and stimulates fibronectin gene expression by enhancing a cAMP response element. Kidney Int 48(Suppl 51):S3-S11, 1995
10. 10. KIKKAWA R, UMEMURA K, HANEDA M, ARIMURA T, EBATA K, SHIGETA Y: Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes 36:240-243, 1987
11. 11. BLEYER AJ, FUMO P, SNIPES ER, GOLDFARB S, SIMMONS DA, ZIYADEH FN: Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubule. Kidney Int 45:659-666, 1994
12. 2 activation. Metabolism 46:41-47, 1997
13. 13. PUGLIESE G, PRICCI F, PUGLIESE F, MENE P, LENTI L, ANDREANI D, GALLI G, CASINI A, BIANCHI S, ROTELLA CM, MARIO UD: Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478-490, 1994
14. +-coupled and facilitative transporters. Diabetoloia 38:291-297, 1995
15. 15. HEILIG CW, LIU Y, ENGLAND RL, FREYTAG SO, GILBERT JD, HEILIG KO, ZHU M, CONCEPCION LA, BROSIUS FCIII: D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: Implications for diabetic nephropathy. Diabetes 46:1030-1039, 1997
16. 16. HEILIG CW, CONCEPCION LA, RISER BL, FREYTAG SO, ZHU M, CORTES P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814, 1995
17. 17. EWEN ME, SLUSS HK, WHITEHOUSE LL, LIVINGSTON DM: TGFβ inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020, 1993
18. 18. IGNOTZ RA, ENDO T, MASSAGUÉ J: Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J Biol Chem 262:6443-6446, 1987
19. 19. SHARMA K, ZIYADEH FN: Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes 44:1139-1146, 1995
20. 20. SCHOECKLMANN HO, RUPPRECHT HD, ZAUNER I, STERZEL RB: TGF-β1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation. Kidney Int 51:1228-1236, 1997
21. 21. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
22. 22. NAKAMURA T, FUKUI M, EBIHARA I, OSADA S, NAGAOKA I, TOMINO Y, KOIDE H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456, 1993
23. 23. MACKAY K, STRIKER LJ, STAUFFER JW, DOI T, AGODOA LY, STRIKER GE: Transforming growth factor-β: Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167, 1989
24. 24. SHARMA K, ZIYADEH FN, ALZAHABI B, MCGOWAN TA, KAPOOR S, KURNIK BRC, KURNIK PB, WEISBERG LS: Increased renal production of transforming growth factor-β1 in patients with type II diabetes. Diabetes 46:854-859, 1997
25. 25. SHARMA K, JIN Y, GUO J, ZIYADEH FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
26. 26. MASUMI A, AKAMATSU Y, KITAGAWA T: Modulation of the synthesis and glycosylation of the glucose transporter protein by transforming growth factor-β1 in Swiss 3T3 fibroblasts. Biochim Biophys Acta 1145:227-234, 1993
27. 27. KITAGAWA T, MASUMI A, AKAMATSU Y: Transforming growth factor-β1 stimulates glucose uptake and the expression of glucose transporter mRNA in quiescent Swiss mouse 3T3 cells. J Biol Chem 266:18066-18071, 1991
28. 28. HANEDA M, KIKKAWA R, MAEDA S, TOGAWA M, KOYA D, HORIDE N, KAJIWARA N, SHIGETA Y: Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Kidney Int 40:188-194, 1991
29. 29. HANEDA M, KIKKAWA R, TOGAWA M, KOYA D, KAJIWARA N, SHIGETA Y: Metabolic actions of insulin-like growth factor I in cultured glomerular mesangial cells. Metabolism 40:1311-1316, 1991
30. 30. WHITESELL RR, GLIEMANN J: Kinetic parameters of transport of 3-O-methylglucose and glucose in adipocytes. J Biol Chem 254: 5276-5283, 1979
31. 31. PALFREYMAN RW, CLARK AE, DENTON RM, HOLMAN GD, KOZKA IJ: Kinetic resolution of the separate GLUT1 and GLUT4 glucose transport activities in 3T3-L1 cells. Biochem J 284:275-281, 1992
32. 32. LONGO N, GRIFFIN LD, LANGLEY SD, ELSAS LJ: Glucose transport by cultured human fibroblasts: Regulation by phorbol esters and insulin. Biochim Biophys Acta 1104:24-30, 1992
33. 33. SUGIMOTO T, HANEDA M, TOGAWA M, ISONO M, SHIKANO T, ARAKI S, NAKAGAWA T, KASHIWAGI A, GUAN KL, KIKKAWA R: Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells. J Biol Chem 271:544-547, 1996
34. 34. LABORDA J: 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19:3998, 1991
35. 35. LONGO N, GRIFFIN LD, ELSAS LJ: Influx and efflux of 3-O-methyl-D-glucose by cultured human fibroblasts. Am J Physiol 254:C628-C633, 1988
36. 36. BROSIUS FC III, BRIGGS JP, MARCUS RG, BARAC-NIETO M, CHARRON MJ: Insulin-responsive glucose transporter expression in renal microvessels and glomeruli. Kidney Int 42:1086-1092, 1992
37. 37. ROLLINS BJ, MORRISON ED, USHER P, FLIER JS: Platelet-derived growth factor regulates glucose transporter expression. J Biol Chem 263:16523-16526, 1988
38. 38. HIRAKI Y, ROSEN OM, BIRNBAUM MJ: Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem 263:13655-13662, 1988
39. 39. BILAN PJ, MITSUMOTO Y, RAMLAL T, KLIP A: Acute and long-term effects of insulin-like growth factor I on glucose transporters in muscle cells: Translocation and biosynthesis. FEBS Lett 298:285-290, 1992
40. 40. MURAKAMI T, NISHIYAMA T, SHIROTANI T, SHINOHARA Y, KAN M, ISHII K, KANAI F, NAKAZURU S, EBINA Y: Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J Biol Chem 267:9300-9306, 1992
41. 41. KIM SJ, DENHEZ F, KM KY, HOLT JT, SPORN MB, ROBERTS AB: Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J Biol Chem 264:19373-19378, 1989
42. 42. KREISBERG JI, GARONI JA, RADNIK R, AYO SH: High glucose and TGFβ1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int 46:1019-1024, 1994
43. 43. AYO SH, RADNIK R, GARONI JA, TROYER DA, KREISBERG JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
44. 44. HANEDA M, ARAKI S, TOGAWA M, SUGIMOTO T, ISONO M, KIKKAWA R: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46:847-853, 1997
45. 45. KOYA D, JIROUSEK MR, LIN YW, ISHII H, KUBOKI K, KING GL: Characterization of protein kinase Cβ isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
46. 46. ISHII H, JIROUSEK MR, KOYA D, TAKAGI C, XIA P, CLERMONT A, BURSELL SE, KERN TS, DALLAS LM, HEATH WF, STRAMM LE, FEENER EP, KING GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKCβ inhibitor. Science 272:728-731, 1996